OgCelix offers a comprehensive portfolio of monoclonal and recombinant antibodies designed for organoid research, with applications in cancer biology, immunology, and neurobiology. With targets covering immune cell markers, tumor-associated antigens, and checkpoint molecules, these antibodies support a wide range of experimental workflows, including organoid characterization, disease modeling, and therapeutic development.
All organoid-specific antibodies are produced in-house with stringent quality control to ensure high specificity, strong affinity, and minimal lot-to-lot variability. Validated across multiple applications — such as flow cytometry (FC), immunohistochemistry (IHC), immunofluorescence (IF), western blotting (WB), and ELISA — they deliver reproducible, high-confidence results for both basic and translational research. Each antibody is selected and validated for organoid workflows. They enable applications such as stem cell lineage tracing, epithelial or neuronal marker staining, or tumor subtype identification.
Extensive testing ensures lot-to-lot consistency and reproducible results.
Offered as unconjugated, fluorophore-conjugated, biotinylated, and recombinant antibodies.
Demonstrated genetic and phenotypic stability across extended culture periods, ensuring reproducibility.
Mouse / IgG1
Human
Liquid
Rabbit / IgG
Human
Liquid
Rabbit / IgG
Human
Liquid
Rabbit / IgG
Human, Mouse
Liquid
Rabbit / IgG
Human, Mouse, Rat
Liquid
Rabbit / IgG
Human, Mouse, Rabbit
Liquid
Mouse / IgG1
Human, Mouse, Rabbit
Liquid
Rabbit / IgG
Human, Mouse, Rat
Liquid
Rabbit / IgG
Human, Mouse, Rat
Liquid
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.